Literature DB >> 23324610

Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors.

Anne Kruse Hollensen1, Rasmus O Bak, Didde Haslund, Jacob Giehm Mikkelsen.   

Abstract

MicroRNAs (miRNAs) are ubiquitous regulators of gene expression that contribute to almost any cellular process. Methods for managing of miRNA activity are attracting increasing attention in relation to diverse experimental and therapeutic applications. DNA-encoded miRNA inhibitors expressed from plasmid or virus-based vectors provide persistent miRNA suppression and options of tissue-directed micromanaging. In this report, we explore the potential of exploiting short, hairpin-shaped RNAs for simultaneous suppression of two or more miRNAs. Based on the "Tough Decoy" (TuD) design, we create dual-targeting hairpins carrying two miRNA recognition sites and demonstrate potent co-suppression of different pairs of unrelated miRNAs by a single DNA-encoded inhibitor RNA. In addition, enhanced miRNA suppression is achieved by expression of RNA polymerase II-transcribed inhibitors carrying clustered TuD hairpins with up to a total of eight miRNA recognition sites. Notably, by expressing clustered TuD inhibitors harboring a single recognition site for each of a total of six miRNAs, we document robust parallel suppression of multiple miRNAs by inhibitor RNA molecules encoded by a single expression cassette. These findings unveil a new potential of TuD-based miRNA inhibitors and pave the way for standardizing synchronized suppression of families or clusters of miRNAs.

Keywords:  Tough Decoy; TuD; miRNA; microRNA inhibition; post-transcriptional gene regulation

Mesh:

Substances:

Year:  2013        PMID: 23324610      PMCID: PMC3672284          DOI: 10.4161/rna.23543

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  22 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 2.  The therapeutic potential of microRNAs: disease modulators and drug targets.

Authors:  Ailbhe M McDermott; Helen M Heneghan; Nicola Miller; Michael J Kerin
Journal:  Pharm Res       Date:  2011-08-05       Impact factor: 4.200

3.  Amelioration of psoriasis by anti-TNF-alpha RNAi in the xenograft transplantation model.

Authors:  Maria Jakobsen; Karin Stenderup; Cecilia Rosada; Brian Moldt; Søren Kamp; Tomas N Dam; Thomas G Jensen; Jacob Giehm Mikkelsen
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

Review 4.  State-of-the-art gene-based therapies: the road ahead.

Authors:  Mark A Kay
Journal:  Nat Rev Genet       Date:  2011-04-06       Impact factor: 53.242

5.  Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors.

Authors:  Rasmus O Bak; Anne Kruse Hollensen; Maria Nascimento Primo; Camilla Darum Sørensen; Jacob Giehm Mikkelsen
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

6.  Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.

Authors:  Robert E Lanford; Elisabeth S Hildebrandt-Eriksen; Andreas Petri; Robert Persson; Morten Lindow; Martin E Munk; Sakari Kauppinen; Henrik Ørum
Journal:  Science       Date:  2009-12-03       Impact factor: 47.728

7.  Regulation of pro-inflammatory cytokines TNFα and IL24 by microRNA-203 in primary keratinocytes.

Authors:  Maria Nascimento Primo; Rasmus O Bak; Beatrice Schibler; Jacob Giehm Mikkelsen
Journal:  Cytokine       Date:  2012-08-20       Impact factor: 3.861

8.  Rapid generation of microRNA sponges for microRNA inhibition.

Authors:  Joost Kluiver; Johan H Gibcus; Chris Hettinga; Annelies Adema; Mareike K S Richter; Nancy Halsema; Izabella Slezak-Prochazka; Ye Ding; Bart-Jan Kroesen; Anke van den Berg
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

9.  Development of transgenic cloned pig models of skin inflammation by DNA transposon-directed ectopic expression of human β1 and α2 integrin.

Authors:  Nicklas Heine Staunstrup; Johannes Madsen; Maria Nascimento Primo; Juan Li; Ying Liu; Peter M Kragh; Rong Li; Mette Schmidt; Stig Purup; Frederik Dagnæs-Hansen; Lars Svensson; Thomas K Petersen; Henrik Callesen; Lars Bolund; Jacob Giehm Mikkelsen
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

10.  A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures.

Authors:  Takeshi Haraguchi; Haruo Nakano; Takanobu Tagawa; Tokimitsu Ohki; Yoshihito Ueno; Tetsuo Yoshida; Hideo Iba
Journal:  Nucleic Acids Res       Date:  2012-01-17       Impact factor: 16.971

View more
  18 in total

Review 1.  Managing microRNAs with vector-encoded decoy-type inhibitors.

Authors:  Rasmus O Bak; Anne Kruse Hollensen; Jacob Giehm Mikkelsen
Journal:  Mol Ther       Date:  2013-06-11       Impact factor: 11.454

2.  Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.

Authors:  Stefan Mockenhaupt; Stefanie Grosse; Daniel Rupp; Ralf Bartenschlager; Dirk Grimm
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

3.  Tough Decoy-Mediated Cardiac Gene Suppression.

Authors:  Changwon Kho
Journal:  Methods Mol Biol       Date:  2022

4.  Delivery of microRNA-21-sponge and pre-microRNA-122 by MS2 virus-like particles to therapeutically target hepatocellular carcinoma cells.

Authors:  Jiawei Zhang; Dandan Li; Rui Zhang; Rongxue Peng; Jinming Li
Journal:  Exp Biol Med (Maywood)       Date:  2021-10-13

Review 5.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

6.  A High-Content Screen Identifies MicroRNAs That Regulate Liver Repopulation After Injury in Mice.

Authors:  Adam M Zahm; Amber W Wang; Yue J Wang; Jonathan Schug; Kirk J Wangensteen; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2019-11-20       Impact factor: 22.682

Review 7.  Tiny giants of gene regulation: experimental strategies for microRNA functional studies.

Authors:  Bruno R Steinkraus; Markus Toegel; Tudor A Fulga
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-07       Impact factor: 5.814

8.  A PCR-Based Method to Construct Lentiviral Vector Expressing Double Tough Decoy for miRNA Inhibition.

Authors:  Huiling Qiu; Jiasheng Zhong; Lan Luo; Nian Liu; Kang Kang; Junle Qu; Wenda Peng; Deming Gou
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

Review 9.  microRNAs in nociceptive circuits as predictors of future clinical applications.

Authors:  Michaela Kress; Alexander Hüttenhofer; Marc Landry; Rohini Kuner; Alexandre Favereaux; David Greenberg; Josef Bednarik; Paul Heppenstall; Florian Kronenberg; Marzia Malcangio; Heike Rittner; Nurcan Uçeyler; Zlatko Trajanoski; Peter Mouritzen; Frank Birklein; Claudia Sommer; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2013-10-17       Impact factor: 5.639

10.  Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells.

Authors:  Benyamin Ranjbar; Louise Bechmann Krogh; Maria Bach Laursen; Maria Nascimento Primo; Sara Correia Marques; Karen Dybkær; Jacob Giehm Mikkelsen
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.